But the defining feature of COP30 was the failure to even mention fossil fuels in the final resolution, even while explicitly ...

RNA interference drug developer SanegeneBio leads our round-up of this week's biotech financings, with a $110 million Series ...

Trichy: A foul smell emanating from Trichy corporation's decanting station in Khajamalai, where sewage from desludging ...

By piling more and more stealth taxes onto businesses, the government is repeating exactly the same mistake of its first ...

In a filing with the New Jersey Department of Labor & Workforce Development, Merck said it expects to cut 204 positions at its headquarters in Rahway between February and May 2026. This marks the ...

Bristol Myers Squibb said it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to ...

IT’S one of the few new challenge shows to capture a fresh audience in recent years – and Tempting Fortune is now being duly ...

FDA’s approval of Bristol Myers Squibb’s Breyanzi as the first CAR T therapy for relapsed or refractory marginal zone lymphoma underscores the therapy’s expanding leadership in B-cell malignancies, ...

Venture capital flow to women-founded companies has stabilized in the post-pandemic environment. BioSpace looks back at five companies that have nabbed the most over the past two decades.

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Beam Therapeutics Inc. is a Strong Buy with promising trial results, a solid cash runway, and key data updates ahead. Click ...

Mica Mountain scored two TDs on two straight plays and held off Arcadia for the 4A Arizona High School football crown.